Advertisement Contracts Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Contracts

March 17, 2021

AstraZeneca to deliver 500,000 more doses of AZD7442 to US

The UK’s Cambridge-based biopharma company AstraZeneca will be delivering 500,000 more doses of AZD7442 to the US after having modified an existing agreement with the US Government.

AstraZeneca to deliver 500,000 more doses of AZD7442 to US